EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies

Chiara Micoli iD, Alessio Crippa iD, Jason T Connor, I‐SPY COVID Consortium, Martin Eklund iD, Andrea Discacciati

Pharmaceutical Statistics · 2026

DOI: 10.1002/pst.70050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2026. Verfasst von Chiara Micoli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Clinical Trials, Phase II as Topic, Computer Simulation, Randomized Controlled Trials as Topic, Research Design. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerfonden, Vetenskapsrådet, Prostatacancerförbundet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bayesian predictive probabilities of success (PPoS) use interim trial data to calculate the probability of trial success. These quantities can be used to optimise trial size or to stop for futility. In this paper, we describe a simulation‐based approach to compute the PPoS for clinical trials with competing event data, for which no specific methodology is currently available. The proposed procedure hinges on modelling the joint distribution of time to event and event type by specifying Bayesian models for the cause‐specific hazards of all event types. This allows the prediction of outcome data at the conclusion of the trial. The PPoS is obtained by numerically averaging the probability of success evaluated at fixed parameter values over the posterior distribution of the parameters. Our work is motivated by two randomised clinical trials: the I‐SPY COVID phase II trial for the treatment of severe COVID‐19 (NCT04488081) and the STHLM3 prostate cancer diagnostic trial (ISRCTN84445406), both of which are characterised by competing event data. We present different modelling alternatives for the joint distribution of time to event and event type and show how the choice of the prior distributions can be used to assess the PPoS under different scenarios. The role of the PPoS analyses in the decision‐making process for these two trials is also discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials, Phase II as TopicComputer SimulationRandomized Controlled Trials as TopicResearch DesignHumansMaleBayes TheoremCOVID-19COVID-19 Drug TreatmentModels, StatisticalProbabilityProstatic Neoplasms

Stichwörter der Autor:innen

Bayesian predictive probability of successclinical trialscompeting eventsinterim analysis

Autor:innen und Institutionen

  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • ConfluenceStat LLC, Cooper City, Florida, USA.
  • University of Central Florida College of Medicine, Orlando, Florida, USA.

ORCID-Profile: Chiara Micoli, Alessio Crippa, Martin Eklund

Förderung

  • Cancerfonden
  • Vetenskapsrådet
  • Prostatacancerförbundet

Zitieren

APA

Micoli, C., Crippa, A., Connor, J. T., I‐SPY COVID Consortium, Eklund, M., & Discacciati, A. (2026). Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies. Pharmaceutical Statistics. https://doi.org/10.1002/pst.70050

Vancouver

Micoli C, Crippa A, Connor JT, I‐SPY COVID Consortium, Eklund M, Discacciati A. Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies. Pharmaceutical Statistics. 2026. doi:10.1002/pst.70050

BibTeX
@article{Micoli2026,
  author = {Micoli, Chiara and Crippa, Alessio and Connor, Jason T and I‐SPY COVID Consortium, I‐SPY COVID Consortium and Eklund, Martin and Discacciati, Andrea},
  title = {Simulation‐Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case Studies},
  journal = {Pharmaceutical Statistics},
  year = {2026},
  doi = {10.1002/pst.70050}
}
Kostenlos starten →